Does Généreux's Aortic Stenosis staging predict waiting-list mortality in patients referred for TAVR?
Patients at Généreux stages 3 and 4 have a significantly higher risk of mortality while on the TAVR waiting list and should be prioritized for intervention.
AIMS Access to transcatheter aortic valve replacement (TAVR) is generally prioritized for symptomatic patients presenting with severe heart failure, syncope, angina, and decrease in left ventricular ejection fraction 60 mmHg sHR, 2.37 (95% CI, 1.36-4.12); P = 0.002. Généreux stages 3 and 4 showed a strong association with waiting-list mortality, more than doubling the risk of death sHR, 2.12 (95% CI, 1.33-3.38); P = 0.002. CONCLUSION These findings suggest that TAVR candidates at Généreux stages 3 and 4 should receive higher priority on the waiting list.
Boyer et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: